论文信息 - A phase II study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma (nccRCC). - 字舞流文

A phase II study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma (nccRCC).

J. Hsieh | N. Agarwal | M. Fishman | M. Michaelson | T. Kuzel | U. Vaishampayan | A. Molina | R. Jain | Thomas E. Hutson | U. Bapat | Sharon Xie